Eric Johnson received his Doctor of Science degree from the Massachusetts Institute of Technology in 1983, followed by a post-doctorate position at Harvard Medical School from 1983-1985. Since 1985, he has been a member of the faculty at the University of Wisconson-Madison. A fellow of the American Academy of Microbiology, Dr. Johnson has served as editor for Applied and Environmental Microbiology, was appointed to the AIBS panel to review DOD Toxicology Program, and involved in CDC’s program for bioterrorism preparedness. He is a past member of the NIH study panel for bioterrorism-related research proposals, and is currently on two NIH-NIAD review panels (Small Business: Infectious Diseases; Microbiology and Bacterial Biodefense). In 2008, Dr. Johnson received the Society for Industrial Microbiology Waksman Outstanding Educator Award.
Dr. Johnson’s laboratory has studied Clostridium botulinum and its neurotoxins for 25 years. During this period, he has adapted and developed methods and technologies for experiments utilized in this project. His laboratory has Category A Select Agent approval, and is one of the few in the United States that has the expertise and ability for comprehensive botulism studies. He is well-published with over 90 articles, has authored numerous book chapters, and has 27 patents as a result of his research.
